Results 231 to 240 of about 1,045,504 (377)

Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2001
M. Egan   +7 more
semanticscholar   +1 more source

Nuclear Sex and Body-build in Schizophrenia [PDF]

open access: green, 1960
Valerie Cowie, Alec Coppen, P. Norman
openalex   +1 more source

Relationships Among Patients' Interpersonal Behaviors in Sessions, Therapist Competence, and the Therapeutic Alliance in Cognitive Behavior Therapy: A Cross‐Lagged Panel Analysis

open access: yesJournal of Clinical Psychology, EarlyView.
ABSTRACT Objective To investigate the reciprocal relationships between patient interpersonal behavior (IB), therapist competence, and the alliance within‐ and between‐persons. Methods A secondary analysis was conducted of a randomized controlled trial with 67 cognitive behavior therapists and 114 patients with depression. The therapists evaluated their
Ulrike Maaß   +4 more
wiley   +1 more source

Gender Differences in Social Cognition and Their Association With Functioning in Individuals With Non‐Affective Psychosis

open access: yesJournal of Clinical Psychology, EarlyView.
ABSTRACT Objectives Previous studies in non‐affective psychosis (NAP) consistently found that patients' functioning is associated with social cognition and gender, with higher functioning in female patients. This study investigated the impact of social cognition on the relationship between gender and functioning, and examined psychometric properties of
Anna‐Lena Bröcker   +4 more
wiley   +1 more source

From risk to chronicity: genetic and neuroimaging insights into the evolving patterns of spontaneous brain activity in schizophrenia. [PDF]

open access: yesPsychol Med
Zhang Y   +16 more
europepmc   +1 more source

Population Pharmacokinetic and Exposure‐Efficacy Analyses of Valbenazine in Patients with Huntington's Disease: Supporting Dose Selection for Chorea Management

open access: yesThe Journal of Clinical Pharmacology, EarlyView.
Abstract Valbenazine improved chorea in individuals with Huntington's disease compared to placebo in a phase 3, placebo‐controlled study (KINECT‐HD). Population pharmacokinetics (PK) and exposure–response (E–R) analyses focused on understanding the PK characteristics of valbenazine and its active metabolite, [+]‐α‐dihydrotetrabenazine ([+]‐α‐HTBZ), and
Hoa Q. Nguyen   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy